Clinical Trial Update: Suramin in Treating Patients With Recurrent Bladder Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating suramin in patients with recurrent bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Suramin (suramin)

Snippet

Sponsor: Cancer Research UK | Conditions: Bladder Cancer | Phase 1 | Status: COMPLETED